Financiën Amgen Inc.

Aandelen

AMGN

US0311621009

Farmaceutische producten

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 17-02-2026			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
373,36 ^USD	+1,13%		+2,39%	+14,07%

12/02	Amgen Inc. Presents at Piper Sandler Virtual Novel Targets in Immunology Symposium, Feb-12-2026 05:00 PM
12/02	Europese Commissie keurt Amgen's Uplizna® goed voor gegeneraliseerde myasthenia gravis	RE

Voorlopige winst- en verliesrekening: Amgen Inc.

Fiscaal tijdperk: december	2021	2022	2023	2024	2025	2026	2027	2028
Omzet ¹	25.979	26.323	28.190	33.424	36.751	37.839	38.554	39.297
Variatie	-	1,32%	7,09%	18,57%	9,95%	2,96%	1,89%	1,93%
EBITDA ¹	15.822	16.178	17.470	20.620	21.370	21.424	21.444	22.162
Variatie	-	2,25%	7,99%	18,03%	3,64%	0,25%	0,09%	3,35%
Bedrijfsresultaat (EBIT) ¹	12.424	12.761	13.399	15.028	16.203	16.664	16.900	17.384
Variatie	-	2,71%	5%	12,16%	7,82%	2,84%	1,42%	2,87%
Betaalde rente ¹	-1.197	-1.406	-2.875	-3.155	-2.755	-2.588	-2.247	-2.053
Resultaat voor belastingen (EBT) ¹	6.701	7.346	7.855	4.609	8.976	9.072	9.494	12.096
Variatie	-	9,63%	6,93%	-41,32%	94,75%	1,06%	4,65%	27,41%
Nettowinst (verlies) ¹	5.893	6.552	6.717	4.090	7.711	7.820	8.660	9.459
Variatie	-	11,18%	2,52%	-39,11%	88,53%	1,41%	10,74%	9,22%
Datum van publicatie	7/02/22	31/01/23	6/02/24	4/02/25	3/02/26	-	-	-

¹USD in Miljoen

Geschatte gegevens

Fiscaal tijdperk: december	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4	2027 Q1	2027 Q2	2027 Q3	2027 Q4
Omzet ¹	5.901	6.526	6.706	6.846	6.238	6.594	6.652	6.839	6.105	6.986	6.903	8.196	7.447	8.388	8.503	9.086	8.149	9.179	9.557	9.866	8.658	9.486	9.695	9.976	9.182	9.612	9.752	9.980
Variatie	-	10,59%	2,76%	2,09%	-8,88%	5,71%	0,88%	2,81%	-10,73%	14,43%	-1,19%	18,73%	-9,14%	12,64%	1,37%	6,86%	-10,31%	12,64%	4,12%	3,23%	-12,24%	9,57%	2,2%	2,89%	-7,95%	4,67%	1,46%	2,34%
EBITDA ¹	3.705	3.966	4.302	3.849	3.981	4.163	4.114	3.920	3.721	4.411	4.298	5.040	4.477	4.915	5.440	5.430	4.986	5.634	5.612	5.138	4.911	5.227	5.253	5.268	-	-	-	-
Variatie	-	7,04%	8,47%	-10,53%	3,43%	4,57%	-1,18%	-4,72%	-5,08%	18,54%	-2,56%	17,26%	-11,17%	9,78%	10,68%	-0,18%	-8,18%	13%	-0,39%	-8,45%	-4,42%	6,43%	0,49%	0,29%	-	-	-	-
Bedrijfsresultaat (EBIT) ¹	2.864	3.111	3.452	2.997	3.140	3.335	3.277	3.009	2.821	3.515	3.403	3.660	3.078	3.873	4.044	4.033	3.599	4.293	4.305	4.006	3.616	4.267	4.346	4.395	3.938	4.209	4.303	4.548
Variatie	-	8,62%	10,96%	-13,18%	4,77%	6,21%	-1,74%	-8,18%	-6,25%	24,6%	-3,19%	7,55%	-15,9%	25,83%	4,42%	-0,27%	-10,76%	19,28%	0,28%	-6,95%	-9,73%	17,99%	1,85%	1,12%	-10,39%	6,88%	2,23%	5,69%
Charge d'intérêts ¹	-285	-281	-296	-335	-295	-328	-368	-415	-543	-419	-759	-821	-824	-808	-776	-747	-723	-694	-685	-653	-635,8	-676,8	-645,7	-610,6	-	-	-	-
Resultaat voor belastingen (EBT) ¹	1.857	558	2.155	2.131	1.675	1.531	2.392	1.748	3.442	1.614	1.947	852	-68	794	3.101	782	1.973	1.568	3.921	1.514	1.741	2.356	2.298	1.944	-	-	-	-
Variatie	-	-69,95%	286,2%	-1,11%	-21,4%	-8,6%	56,24%	-26,92%	96,91%	-53,11%	20,63%	-56,24%	-107,98%	1.267,65%	290,55%	-74,78%	152,3%	-20,53%	150,06%	-61,39%	14,99%	35,32%	-2,46%	-15,4%	-	-	-	-
Nettowinst (verlies) ¹	1.646	464	1.884	1.899	1.476	1.317	2.143	1.616	2.841	1.379	1.730	767	-113	746	2.830	627	1.730	1.432	3.216	1.333	1.682	2.123	2.183	2.131	1.813	2.006	2.063	2.249
Variatie	-	-71,81%	306,03%	0,8%	-22,27%	-10,77%	62,72%	-24,59%	75,8%	-51,46%	25,45%	-55,66%	-114,73%	760,18%	279,36%	-77,84%	175,92%	-17,23%	124,58%	-58,55%	26,22%	26,2%	2,83%	-2,37%	-14,94%	10,65%	2,84%	9,02%
Datum van publicatie	27/04/21	3/08/21	2/11/21	7/02/22	27/04/22	4/08/22	3/11/22	31/01/23	27/04/23	3/08/23	31/10/23	6/02/24	2/05/24	6/08/24	30/10/24	4/02/25	1/05/25	5/08/25	4/11/25	3/02/26	-	-	-	-	-	-	-	-

¹USD in Miljoen

Geschatte gegevens

Balansprognose: Amgen Inc.

Fiscaal tijdperk: december	2021	2022	2023	2024	2025	2026	2027	2028
Nettoschuld ¹	25.272	29.640	53.669	48.126	45.475	39.275	32.643	25.926
Variatie	-	17,28%	81,07%	-10,33%	-5,51%	-13,63%	-16,89%	-20,58%
Datum van publicatie	7/02/22	31/01/23	6/02/24	4/02/25	3/02/26	-	-	-

¹USD in Miljoen

Geschatte gegevens

Verwachte kasstroom: Amgen Inc.

Fiscaal tijdperk: december	2021	2022	2023	2024	2025	2026	2027	2028
CAPEX ¹	880	936	1.112	1.096	1.858	1.960	1.794	1.892
Variatie	-	6,36%	18,8%	-1,44%	69,53%	5,52%	-8,47%	5,42%
Vrije kasstroom (FCF) ¹	8.381	8.785	7.359	10.394	8.100	12.433	12.750	13.407
Variatie	-	4,82%	-16,23%	41,24%	-22,07%	53,49%	2,55%	5,15%
Datum van publicatie	7/02/22	31/01/23	6/02/24	4/02/25	3/02/26	-	-	-

¹USD in Miljoen

Geschatte gegevens

Verwachte financiële ratio's: Amgen Inc.

Fiscaal tijdperk: december	2021	2022	2023	2024	2025	2026	2027	2028
Winstgevendheid
EBITDA-marge (%)	60,9%	61,46%	61,97%	61,69%	58,15%	56,62%	55,62%	56,4%
EBIT-marge (%)	47,82%	48,48%	47,53%	44,96%	44,09%	44,04%	43,83%	44,24%
EBT-marge (%)	25,79%	27,91%	27,86%	13,79%	24,42%	23,97%	24,62%	30,78%
Nettomarge (%)	22,68%	24,89%	23,83%	12,24%	20,98%	20,67%	22,46%	24,07%
FCF-marge (%)	32,26%	33,37%	26,11%	31,1%	22,04%	32,86%	33,07%	34,12%
Vrije kasstroom/nettoresultaat (%)	142,22%	134,08%	109,56%	254,13%	105,04%	158,99%	147,24%	141,74%
Winstgevendheid
ROA	15,79%	15,16%	12,37%	11,36%	12,98%	10,34%	11,26%	11,82%
ROE	121,63%	184,73%	202,85%	177,29%	162,88%	112,83%	94,8%	80,6%
Financiële gezondheid
Hefboom (schuld/ebitda)	1,6x	1,83x	3,07x	2,33x	2,13x	1,83x	1,52x	1,17x
Schuld/vrije kasstroom	3,02x	3,37x	7,29x	4,63x	5,61x	3,16x	2,56x	1,93x
Kapitaalintensiteit
Kapitaaluitgaven/omzet (%)	3,39%	3,56%	3,94%	3,28%	5,06%	5,18%	4,65%	4,81%
CAPEX / EBITDA (%)	5,56%	5,79%	6,37%	5,32%	8,69%	9,15%	8,37%	8,54%
CAPEX / FCF (%)	10,5%	10,65%	15,11%	10,54%	22,94%	15,77%	14,07%	14,11%
Bestanddelen per aandeel
Kasstroom per aandeel ¹	16,16	17,97	15,75	21,24	18,37	25,97	25,02	32,22
Variatie	-	11,18%	-12,37%	34,89%	-13,49%	41,34%	-3,67%	28,78%
Dividend per aandeel ¹	7,04	7,76	8,52	9	-	10,03	10,71	11,43
Variatie	-	10,23%	9,79%	5,63%	-	-	6,75%	6,77%
Nettoactief per aandeel ¹	12,01	6,856	11,65	10,94	16,06	22,38	28,95	38,44
Variatie	-	-42,9%	69,91%	-6,05%	46,77%	39,34%	29,33%	32,8%
WPA ¹	10,28	12,11	12,49	7,56	14,23	14,8	16,19	17,52
Variatie	-	17,8%	3,14%	-39,47%	88,23%	4%	9,37%	8,21%
Aantal aandelen (in duizend)	563.266	533.579	535.178	537.533	538.481	539.068	539.068	539.068
Datum van publicatie	7/02/22	31/01/23	6/02/24	4/02/25	3/02/26	-	-	-